Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

A Paschen; A Sucker; B Hill; I Moll; M Zapatka; XD Nguyen; GC Sim; I Gutmann; J Hassel; Jürgen Christian Becker; A Steinle; D Schadendorf; Selma Ugurel-Becker

doi:10.1158/1078-0432.CCR-09-0886

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

A Paschen
, A Sucker
, B Hill
, I Moll
, M Zapatka
, XD Nguyen
, GC Sim
, I Gutmann
, J Hassel
, Jürgen Christian Becker
, A Steinle
, D Schadendorf
, Selma Ugurel-Becker (Last author)

Research output: Contribution to journal › Research article

145 Citations (Web of Science)

Original language	English
Journal	Clinical Cancer Research
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-0886
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

DOI

10.1158/1078-0432.CCR-09-0886

Links

Cite this

Paschen, A., Sucker, A., Hill, B., Moll, I., Zapatka, M., Nguyen, XD., Sim, GC., Gutmann, I., Hassel, J., Becker, J. C., Steinle, A., Schadendorf, D., & Ugurel-Becker, S. (2009). Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-09-0886

@article{f932a1820b9f4a2e956325060b1c4e7d,

title = "Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.",

author = "A Paschen and A Sucker and B Hill and I Moll and M Zapatka and XD Nguyen and GC Sim and I Gutmann and J Hassel and Becker, \{J{\"u}rgen Christian\} and A Steinle and D Schadendorf and Selma Ugurel-Becker",

year = "2009",

doi = "10.1158/1078-0432.CCR-09-0886",

language = "English",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

Paschen, A, Sucker, A, Hill, B, Moll, I, Zapatka, M, Nguyen, XD, Sim, GC, Gutmann, I, Hassel, J, Becker, JC, Steinle, A, Schadendorf, D & Ugurel-Becker, S 2009, 'Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.', Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-09-0886

TY - JOUR

T1 - Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

AU - Paschen, A

AU - Sucker, A

AU - Hill, B

AU - Moll, I

AU - Zapatka, M

AU - Nguyen, XD

AU - Sim, GC

AU - Gutmann, I

AU - Hassel, J

AU - Becker, Jürgen Christian

AU - Steinle, A

AU - Schadendorf, D

A2 - Ugurel-Becker, Selma

PY - 2009

Y1 - 2009

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000269024900024

UR - https://pubmed.ncbi.nlm.nih.gov/19671853

U2 - 10.1158/1078-0432.CCR-09-0886

DO - 10.1158/1078-0432.CCR-09-0886

M3 - Research article

C2 - 19671853

SN - 1078-0432

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -